As of the latest SEC filings, RECURSION PHARMACEUTICALS, INC. (RXRX) is held by 170 institutional funds. The largest fund shareholder is ARK Innovation ETF (ARKK), holding an estimated $75,199,550.04 in market value, representing 1.16% of its portfolio.
Funds holding RECURSION PHARMACEUTICALS, INC. (RXRX)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- RXRX
- CIK:
- 0001601830
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
ARKK
ARK Innovation ETF
|
ETF | Independent / Boutique | 1.16% | $75,199,550.04 | 21,733,974 | Apr 30, 2026 | Jun 23, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 0.69% | $51,368,808.77 | 16,732,511 | Mar 31, 2026 | May 28, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $47,855,488.49 | 15,588,107 | Mar 31, 2026 | May 28, 2026 |
|
ARKG
ARK Genomic Revolution ETF
|
ETF | Independent / Boutique | 3.51% | $43,420,370.40 | 12,549,240 | Apr 30, 2026 | Jun 23, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.02% | $35,086,170.40 | 11,428,720 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.05% | $34,268,589.49 | 11,162,407 | Mar 31, 2026 | May 28, 2026 |
|
VISGX
VANGUARD SMALL-CAP GROWTH INDEX FUND
|
ETF | Vanguard | 0.05% | $19,627,750.28 | 6,393,404 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.02% | $17,695,648.85 | 5,764,055 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.05% | $15,686,972.22 | 4,533,807 | Apr 30, 2026 | Jun 26, 2026 |
|
VWUAX
VANGUARD U.S. GROWTH FUND
|
MF | Vanguard | 0.03% | $11,959,014.29 | 3,258,587 | Feb 28, 2026 | Apr 28, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.09% | $11,494,736.98 | 3,744,214 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.03% | $10,683,960.87 | 2,911,161 | Feb 28, 2026 | Apr 24, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.13% | $10,498,960.99 | 3,419,857 | Mar 31, 2026 | May 28, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.04% | $9,189,015.73 | 2,503,819 | Feb 28, 2026 | Apr 24, 2026 |
|
VEXPX
VANGUARD EXPLORER FUND
|
MF | Vanguard | 0.04% | $8,097,690.58 | 2,340,373 | Apr 30, 2026 | Jun 26, 2026 |
|
ROBT
First Trust Nasdaq Artificial Intelligence and Robotics ETF
|
ETF | First Trust | 1.31% | $8,012,905.69 | 2,610,067 | Mar 31, 2026 | May 21, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.05% | $6,917,373.81 | 1,884,843 | Feb 28, 2026 | Apr 28, 2026 |
|
BDSKX
BlackRock Advantage Small Cap Core Fund
|
MF | BlackRock / iShares | 0.11% | $5,121,198.74 | 1,395,422 | Feb 27, 2026 | Apr 24, 2026 |
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.00% | $4,073,655.96 | 1,109,988 | Feb 28, 2026 | Apr 24, 2026 |
|
VHCIX
VANGUARD HEALTH CARE INDEX FUND
|
ETF | Vanguard | 0.02% | $4,033,983.26 | 1,099,178 | Feb 28, 2026 | Apr 28, 2026 |
|
-
ARK Venture Fund
|
CEF | Independent / Boutique | 0.44% | $3,783,593.04 | 1,093,524 | Apr 30, 2026 | Jun 23, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $3,686,195.71 | 1,004,413 | Feb 28, 2026 | Apr 24, 2026 |
|
SWSSX
Schwab Small-Cap Index Fund
|
MF | Charles Schwab | 0.05% | $3,484,247.68 | 1,007,008 | Apr 30, 2026 | Jun 25, 2026 |
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
ETF | Direxion | 0.64% | $3,316,666.04 | 958,574 | Apr 30, 2026 | Jun 29, 2026 |
|
FCFMX
Fidelity Series Total Market Index Fund
|
MF | Fidelity | 0.00% | $2,876,850.61 | 783,883 | Feb 28, 2026 | Apr 24, 2026 |
Advertisement (320x50)